George Magrath - 01 Nov 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role: Chief Executive Officer
Signature: /s/ Stephanie Swan , by Power of Attorney
Issuer symbol: IRD
Transactions as of: 01 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Nov 2023, 09:29:14 UTC
Next filing: 20 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+400,000		$0.000000	400,000	01 Nov 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+600,000		$0.000000	600,000	01 Nov 2023	Common Stock	600,000	$2.87	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of November 1, 2023.
F2	The option will vest with respect to 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each full month over the subsequent 36 months, subject to continuing service.